Literature DB >> 28300858

Comparison of Two Swiss-Designed Hyaluronic Acid Gels: Six-Month Clinical Follow-Up.

Patrick Micheels, Didier Sarazin, Stéphanie Besse, Badwi Eliasd.   

Abstract

The aim of this paper is to compare 2 hyaluronic acid gel fillers from the same Swiss manufacturer and with the same indications: filling of line wrinkles and folds. The products differ by their cross-linking process. With very simple easy-to-reproduce tests, cohesivity and resistance to traction forces were examined. Also, both gels were injected under ultrasound control in the mid reticular dermis of three subjects. The papules were controlled under ultrasound and biopsies at D0 and D15. Results showed significant differences between the 2 gels in all the tests. The new gel, manufactured with a lower-crosslinking density, seems to benefit from better integration in the tissue of the mid reticular dermis and to have a more cohesive nature than its comparator from a previous crosslinking technology. Under clinical observation, the range of new products present excellent tissue integration properties. <p><em>J Drugs Dermatol. 2017;16(2):154-161.</em></p>.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28300858

Source DB:  PubMed          Journal:  J Drugs Dermatol        ISSN: 1545-9616            Impact factor:   2.114


  4 in total

1.  Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate-to-severe nasolabial folds: A 64-week, prospective, multicenter, controlled, randomized, double-blind and within-subject study.

Authors:  Joely Kaufman-Janette; Susan C Taylor; Sue Ellen Cox; Susan H Weinkle; Stacy Smith; Brian M Kinney
Journal:  J Cosmet Dermatol       Date:  2019-08-24       Impact factor: 2.696

2.  Advanced Concepts in Rheology for the Evaluation of Hyaluronic Acid-Based Soft Tissue Fillers.

Authors:  Jimmy Faivre; Mélanie Gallet; Elodie Tremblais; Patrick Trévidic; François Bourdon
Journal:  Dermatol Surg       Date:  2021-05-01       Impact factor: 2.914

3.  Postmarket Safety Surveillance of Delayed Complications for Recent FDA-Approved Hyaluronic Acid Dermal Fillers.

Authors:  Joel L Cohen; Jessica Hicks; Alessandra Nogueira; Vanessa Lane; Bill Andriopoulos
Journal:  Dermatol Surg       Date:  2022-02-01       Impact factor: 3.398

4.  Efficacy and Safety of a New Resilient Hyaluronic Acid Filler in the Correction of Moderate-to-Severe Dynamic Perioral Rhytides: A 52-Week Prospective, Multicenter, Controlled, Randomized, Evaluator-Blinded Study.

Authors:  Hema Sundaram; Ava Shamban; Joel Schlessinger; Joely Kaufman-Janette; John H Joseph; Mark Lupin; Zoe Draelos; Wayne Carey; Stacy Smith; Laura Eaton
Journal:  Dermatol Surg       Date:  2022-01-01       Impact factor: 3.398

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.